Population frequencies of inherited neuromuscular diseases???A world survey, Neuromuscular Disorders, vol.1, issue.1, pp.19-29, 1991. ,
DOI : 10.1016/0960-8966(91)90039-U
Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21, Nature Genetics, vol.30, issue.1, pp.21-22, 2002. ,
DOI : 10.1038/ng796
The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease, Nature Genetics, vol.30, issue.1, pp.22-25, 2002. ,
DOI : 10.1038/ng798
Mutations in the ganglioside-induced differentiation-associated protein-1 (GDAP1) gene in intermediate type autosomal recessive Charcot-Marie-Tooth neuropathy, Brain, vol.126, issue.3, pp.642-649, 2003. ,
DOI : 10.1093/brain/awg068
Mitochondrial complex I deficiency in GDAP1-related autosomal dominant Charcot-Marie-Tooth disease (CMT2K), neurogenetics, vol.292, issue.2, pp.145-150, 2009. ,
DOI : 10.1007/s10048-008-0166-9
A novel GDAP1 Q218E mutation in autosomal dominant Charcot-Marie-Tooth disease, Journal of Human Genetics, vol.14, issue.4, pp.360-364, 2008. ,
DOI : 10.1007/s10038-008-0249-3
Genetics of Charcot-Marie-Tooth disease type 4A: mutations, inheritance, phenotypic variability, and founder effect, Journal of Medical Genetics, vol.42, issue.4, pp.358-365, 2005. ,
DOI : 10.1136/jmg.2004.022178
Linkage of a locus (CMT4A) for autosomal recessive Charcot-Marie-Tooth disease to chromosome 8q, Human Molecular Genetics, vol.2, issue.10, pp.1625-1628, 1993. ,
DOI : 10.1093/hmg/2.10.1625
Isolation of 10 Differentially Expressed cDNAs in Differentiated Neuro2a Cells Induced Through Controlled Expression of the GD3 Synthase Gene, Journal of Neurochemistry, vol.66, issue.5, pp.1781-1790, 1999. ,
DOI : 10.1046/j.1471-4159.1999.0721781.x
Evolutionary and Structural Analyses of GDAP1, Involved in Charcot-Marie-Tooth Disease, Characterize a Novel Class of Glutathione Transferase-Related Genes, Molecular Biology and Evolution, vol.21, issue.1, pp.176-187, 2004. ,
DOI : 10.1093/molbev/msh013
Functional characterisation of ganglioside-induced differentiation-associated protein 1 as a glutathione transferase, Biochemical and Biophysical Research Communications, vol.347, issue.4, pp.859-866, 2006. ,
DOI : 10.1016/j.bbrc.2006.06.189
GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria, Human Molecular Genetics, vol.14, issue.8, pp.1087-1094, 2005. ,
DOI : 10.1093/hmg/ddi121
Targeting and Function of the Mitochondrial Fission Factor GDAP1 Are Dependent on Its Tail-Anchor, PLoS ONE, vol.15, issue.4, p.5160, 2009. ,
DOI : 10.1371/journal.pone.0005160.s006
Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network, The Journal of Cell Biology, vol.41, issue.7, pp.1067-1078, 2005. ,
DOI : 10.1038/ng1341
Cell expression of GDAP1 in the nervous system and pathogenesis of Charcot-Marie-Tooth type 4A disease, Journal of Cellular and Molecular Medicine, vol.59, issue.2, pp.679-689, 2008. ,
DOI : 10.1016/S0960-8966(03)00093-2
Mitochondrial dysfunction and pathophysiology of Charcot???Marie???Tooth disease involving GDAP1 mutations, Experimental Neurology, vol.227, issue.1, pp.31-41, 2011. ,
DOI : 10.1016/j.expneurol.2010.09.006
Novel mutations in the GDAP1 gene in patients affected with early-onset axonal Charcot-Marie-Tooth type 4A, Neuromuscular Disorders, vol.19, issue.7, pp.476-480, 2009. ,
DOI : 10.1016/j.nmd.2009.04.014
Variability of disease progression in a family with autosomal recessive CMT associated with a S194X and new R310Q mutation in the GDAP1 gene, Neuromuscular Disorders, vol.13, issue.4, pp.341-346, 2003. ,
DOI : 10.1016/S0960-8966(02)00281-X
den Dunnen JT: LOVD v.2.0: the next generation in gene variant databases. Human mutation, pp.557-563, 2011. ,
Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker. Human mutation, pp.6-13, 2008. ,
Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion, Human Mutation, vol.10, issue.1, pp.7-12, 2000. ,
DOI : 10.1002/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N
Standardizing mutation nomenclature: why bother? Hum Mutat, pp.181-182, 2003. ,
The GST domain of GDAP1 is a frequent target of mutations in the dominant form of axonal Charcot Marie Tooth type 2K, Journal of Medical Genetics, vol.47, issue.10, pp.712-716, 2010. ,
DOI : 10.1136/jmg.2010.077909
URL : https://hal.archives-ouvertes.fr/hal-00557397
Charcot???Marie???Tooth diseases, Revue neurologique, vol.160, pp.1221-1229, 2004. ,
DOI : 10.1017/CBO9781139087711.012
Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases, Brain, vol.120, issue.5, pp.120813-823, 1997. ,
DOI : 10.1093/brain/120.5.813
Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients, Brain, vol.126, issue.1, pp.134-151, 2003. ,
DOI : 10.1093/brain/awg012
Electrophysiological features of inherited demyelinating neuropathies: A reappraisal in the era of molecular diagnosis, Muscle & Nerve, vol.43, issue.10, pp.1472-1487, 2000. ,
DOI : 10.1002/1097-4598(200010)23:10<1472::AID-MUS3>3.0.CO;2-#
Autosomal-recessive forms of demyelinating Charcot-Marie-Tooth disease, NeuroMolecular Medicine, vol.8, issue.1-2, pp.75-86, 2006. ,
DOI : 10.1385/NMM:8:1-2:75
Simultaneous MFN2 and GDAP1 mutations cause major mitochondrial defects in a patient with CMT, Neurology, vol.76, issue.17, pp.1524-1526, 2011. ,
DOI : 10.1212/WNL.0b013e318217e77d
an online database for OPA1 mutations, Human mutation, vol.25, pp.1423-428, 2005. ,
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A, Nature Genetics, vol.8, issue.5, pp.449-451, 2004. ,
DOI : 10.1083/jcb.200209124
A Lethal Defect of Mitochondrial and Peroxisomal Fission, New England Journal of Medicine, vol.356, issue.17, pp.1736-1741, 2007. ,
DOI : 10.1056/NEJMoa064436